Opthea Stock Today
Opthea is selling for under 3.41 as of the 4th of April 2025; that is 2.01 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 3.25. The performance scores are derived for the period starting the 15th of April 2023 and ending today, the 4th of April 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 12th of April 2012 | Category Healthcare | Classification Health Care |
Valuation Profit Patterns
Check how we calculate scores
Opthea Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Old Name | Optizen Labs SA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Australia All Ordinaries, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsOpthea can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Opthea's financial leverage. It provides some insight into what part of Opthea's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Opthea (OPT) is traded on NASDAQ Exchange in USA. It is located in 650 Chapel Street, South Yarra, VIC, Australia, 3141 and employs 33 people. Opthea is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 524.82 M. Opthea runs under Biotechnology sector within Health Care industry. The entity has 153.91 M outstanding shares of which 522.15 K shares are now shorted by investors with about 12.21 days to cover.
Opthea has about 44.63 M in cash with (161.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01.
Check Opthea Probability Of Bankruptcy
Opthea Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Frazier Financial Advisors, Llc | 2024-09-30 | 0.0 | |
| Royal Bank Of Canada | 2024-09-30 | 0.0 | |
| Jane Street Group Llc | 2024-12-31 | 0.0 | |
| Bank Of Montreal | 2024-09-30 | 0.0 | |
| Bmo Capital Markets Corp. | 2024-09-30 | 0.0 | |
| Stratos Wealth Partners, Ltd | 2024-12-31 | 0.0 | |
| Victory Capital Management Inc. | 2024-09-30 | 0.0 | |
| Teacher Retirement System Of Texas | 2024-09-30 | 0.0 | |
| Vgi Partners Pty Ltd | 2024-12-31 | 2.9 M | |
| Baker Bros Advisors Lp | 2024-12-31 | 2.2 M | |
| Hsbc Holdings Plc | 2024-12-31 | 142.5 K |
Opthea Historical Income Statement
Opthea Stock Against Markets
Opthea Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Opthea stock to make a market-neutral strategy. Peer analysis of Opthea could also be used in its relative valuation, which is a method of valuing Opthea by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Opthea Corporate Management
| Jen Watts | VP Operations | Profile | |
| Karen CPA | VP Secretary | Profile | |
| CPA CPA | Chief Officer | Profile | |
| MD MA | Chief Advisor | Profile | |
| Sarika Gulhar | Executive Resources | Profile | |
| Michael Gerometta | Manufacturing Chemistry | Profile | |
| Peter MBA | Chief Officer | Profile |
Additional Tools for Opthea Stock Analysis
When running Opthea's price analysis, check to measure Opthea's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opthea is operating at the current time. Most of Opthea's value examination focuses on studying past and present price action to predict the probability of Opthea's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opthea's price. Additionally, you may evaluate how the addition of Opthea to your portfolios can decrease your overall portfolio volatility.